VIM and breast cancer: In the present study, CLDN6 expression in breast cancer cells was upregulated by SB431542 treatment, and, subsequently, the invasion and migration were suppressed, along with the upregulation of epithelial marker E-cadherin and the downregulation of mesenchymal markers SNAIL, N-cadherin, and vimentin.